Checkpoint Capital’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.67M | Sell |
106,991
-29,614
| -22% | -$1.29M | 2.18% | 7 |
|
|
2025
Q1 | $3.74M | Buy |
136,605
+59,070
| +76% | +$1.62M | 2.05% | 9 |
|
|
2024
Q4 | $3.12M | Buy |
+77,535
| New | +$3.12M | 1.59% | 14 |
|
|
2024
Q3 | – | Sell |
-82,000
| Closed | -$2.45M | – | 19 |
|
|
2024
Q2 | $2.45M | Buy |
+82,000
| New | +$2.45M | 1.48% | 11 |
|